Drug Enforcement D-099-2013

Presence of Particulate Matter: Report of a vial containing visible particulate matter embedded in the glass wall which has the potential to dislodge resulting in the presence of particulate matter in the product.

Status

Terminated

Classification

Class II

Report Date

December 26, 2012

Termination Date

May 8, 2014

Product Information

Product description
Lidocaine HCl Injection, USP, 1% (10 mg/mL), 30 mL Single-dose Teartop Vial, packaged in 25-count vials per carton, Rx only, Hospira, Inc., Lake Forest, IL 60045; NDC 0409-4279-02.
Product quantity
120,350 vials
Reason for recall
Presence of Particulate Matter: Report of a vial containing visible particulate matter embedded in the glass wall which has the potential to dislodge resulting in the presence of particulate matter in the product.
Recall initiation reason
Initial firm notification
Letter
Distribution pattern
Nationwide

Location & Firm

Recalling firm
Hospira, Inc.
Address
600 N Field Dr Bldg J45

United States
Voluntary / Mandated
Voluntary: Firm initiated
Status date

Codes & Dates

Recall number
D-099-2013
Event ID
63913
Recall initiation date
October 4, 2012
Center classification date
December 20, 2012
Code info
Lot #: 14-277-DK*, Exp 02/01/14; * may be followed by 01
More code info